Page last updated: 2024-11-04

sulfinpyrazone and Ischemia

sulfinpyrazone has been researched along with Ischemia in 2 studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weiss, HJ1
Gotshall, RA1
Harker, LA1

Reviews

1 review available for sulfinpyrazone and Ischemia

ArticleYear
Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
    American heart journal, 1976, Volume: 92, Issue:1

    Topics: Anticoagulants; Aspirin; Blood Platelets; Brain; Clofibrate; Dextrans; Dipyridamole; Humans; Ischemi

1976

Other Studies

1 other study available for sulfinpyrazone and Ischemia

ArticleYear
Using antithrombotic therapy in ischemic cerebrovascular disease.
    Geriatrics, 1977, Volume: 32, Issue:11

    Topics: Aspirin; Brain; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Intra

1977